Anticoagulation for people with cancer and central venous catheters.
CONCLUSIONS: The evidence was not conclusive for the effect of LMWH on mortality, the effect of VKA on mortality and catheter-related VTE, and the effect of LMWH compared to VKA on mortality and catheter-related VTE. We found moderate-certainty evidence that LMWH reduces catheter-related VTE compared to no LMWH. People with cancer with CVCs considering anticoagulation should balance the possible benefit of reduced thromboembolic complications with the possible harms and burden of anticoagulants.
PMID: 29856471 [PubMed - as supplied by publisher]
Source: Cochrane Database of Systematic Reviews - Category: General Medicine Authors: Kahale LA, Tsolakian IG, Hakoum MB, Matar CF, Barba M, Yosuico VE, Terrenato I, Sperati F, Schünemann H, Akl EA Tags: Cochrane Database Syst Rev Source Type: research
More News: Bleeding | Cancer | Cancer & Oncology | Central Venous Catheterization | Children | Conferences | Databases & Libraries | General Medicine | Pulmonary Thromboembolism | Study | Thrombocytopenia | Thrombosis | Vitamin K | Vitamins